Delayed positive thallium uptake in large b-cell non-hodgkin's malignant lymphoma

Journal of Nuclear Medicine

Volumn 38, Issue 8, 1997, Pages 1213-1215

  Abdel Dayem, Hussein M ^a   Naddaf, Sleiman Y ^a   Omar, Walid S ^a   Aziz, Mohamed ^a   Gillooley, John ^a  

^a ST VINCENT S HOSPITAL   (United States)

Author keywords

AIDS; Thallium 201 chloride; Undifferentiated lymphoma

Indexed keywords

THALLIUM CHLORIDE TL 201;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LARGE CELL LYMPHOMA; LYMPHADENOPATHY; MALE; MEDIASTINUM MASS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

CITRATES; GALLIUM; GALLIUM RADIOISOTOPES; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; THALLIUM; THALLIUM RADIOISOTOPES; TIME FACTORS;

EID: 0030843241     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Abdel-Dayem UM, Scott AM, Macapinlac HA, El-Gazzar AH, Larson SM. Role of Tl-201 chloride and Tc-99m-sestamibi in tumor imaging. In: Freeman LM, ed. Nuclear Medicine Annual New York. NY: Raven Press; 1994:181-234.
2. El-Gazzar AH, Fernandez-Ulloa M, Silberstein EG. Thallium-201 as a tumor imaging agent: current status and future consideration. Nucl Med Commun 1993;14:96- 99.
3. El-Cia/zar All. Malki A, Abdel-Dayem HM, et al. Role of Tl-201 in the diagnosis of solitary bone lesions. Nucl Med Commun 1989:477 485.
4. Waxman A, Ramanna L, Memsie L, Silberman A, Brennar J. Thallium scintigraphy in the differentiation of malignant from benign mass abnormalities of the breast [J. ./ Nucl Med 1990:31:767.
5. Waxman AD, Ramannah L, Memsie ED, et al. Thallium seintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993;34:18 23.
6. Ramannah E, Waxman AD. Weiss A, Rosen G. Thallium-201 scan patterns in bone and soft tissue sarcoma [J. ./ Nucl Med 1992;33:843.
7. Kirn KT, Black KE, Marcino D, et al. Thallium-201 SPECT imaging of brain tumors; methods and results. J Nucl Med 1990; 19:965- 969.
8. Kaplan WD. Takuovian T, Morris J, et al. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 1987;28:47-52.
9. Gruber MC, Hochberg FH. Editorial: systemic evalution of primary brain tumors. J Nucl Med 1990:31:969 971.
10. Sjoholm B A, Elmquist D, Rehncrona S, Rosen I, Sal ford E. Thallium-201 and SPECT distinguishes high-grade from low-grade gliomas [J. J Nucl Med 1992;33:868.
11. Kosuda S. Aoki S, Suzuki K, Nakamura O, Shidara N. Réévaluation of quantitative thallium-201 brain SPECT for brain tumors [J. J Nucl Med 1992;33:844.
12. Hoh CK, Khannas S, Harris GC, et al. Evaluation of brain tumor recurrence with Tl-201 SPECT studies: correlation with FDG PET and histological results [], J Nucl Med 1992:33:867.
13. Ramannah E, Waxman AD, Binney G, Waxman S, Mirra J, Rosen G. Tl-201 scintigraphy in bone sarcoma: comparison with Ga-67 and Tc-99m-MDP in the evaluation of ehemotherapeutic response. ./ Nucl Med 1990;31:567-571.
14. Caluser C, Macapinlac H, Meyers P, et al. The relationship between thallium uptake. blood flow und blood pool radioactivity in bone and soft tissue tumors. Clin Niicl Meet 1992; 17:565 571.
15. Kostakoglu L. David PM, Divgi CR, Botet J, Healy J, Larson SM. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas. Eur J Nucl Meet. 1995;22:1232 1237.
16. Sehweil AM, Mckillop JH, Milroy R, et al. Mechanism of TI-201 uptake in tumors. Eur J Nucl Med \989; 15:376 - 379.
17. Ando A, Ando I. Katayana M, et al. Biodistribution of Tl-201 in tumor bearing animals and inflammatory lesions induced animals. Eur J Nucl Med 1987;I2:567 572.
18. Sehweil A, McKillop JH, Ziada Ü, Al-Sayed M, Abdel-Dayem UM, Omar YT. The optimum time for tumor imaging with thallium-201. Eur .1 Nucl Mfd 1988:13:527 529.
19. Kaplan WD, Southee ML, Annese MS, et al. Evaluating low and intermediate grade non-Hodgkin's lymphoma (NHL) with gallium-67 and thallium-201 imaging [AbstractJ. ./ Nucl Mal 1990;31:793.
20. Abdel-Dayem HM, DiFabrizio L, Bag R, Aras T, Turoglu HT. Kempf .IS, Habbab N, Pescatore F, Sadik A, Kowalsky W. Evaluation of sequential thallium and gallium scans in AIDS patients. J Nucl Med 1996:37:1662 1667.
21. Abdel-Dayem HM, DiFabrizio L, Aras T, et al. Prospective evaluation of sequential thallium-201 chloride and gallium-67 citrate scans in AIDS patients [J. J Nucl Mcd 1993;34:172P.
22. Lee VW. AlDS-related Kaposi's sarcoma findings in thallium-201 seintigraphy. Am J Roemgenol 1988; 151:1233 -1235.
23. Ganz Wl, Nguyen TQ, Benedetto MP. et al. Use of early, late and SPECT thallium imaging in evaluating activity of soft tissue and bone tumors [J. ./ Nucl Med 1993;34:32P.
24. Ueda T, Kaszi Y, Yakisaka S, et al. Time sequential single-photon emission computed tomography studies in brain tumor using thallium-201. Eur J Nucl Med 1993;20:138.
25. Chen DCP, Ma GQ, Ansari A, et al. Optimal imaging time for thallium as a tumor agent in patients with lymphoma [J. J Nucl Med 1992;33(suppl):44P.